News
HC Wainwright & Co. Maintains Neutral on Sage Therapeutics, Lowers Price Target to $25
26 Apr 24
News, Price Target, Analyst Ratings
Mizuho Maintains Neutral on Sage Therapeutics, Lowers Price Target to $18
26 Apr 24
News, Price Target, Analyst Ratings
Canaccord Genuity Maintains Hold on Sage Therapeutics, Lowers Price Target to $17
26 Apr 24
News, Price Target, Analyst Ratings
Needham Reiterates Hold on Sage Therapeutics
26 Apr 24
News, Reiteration, Analyst Ratings
Needham Reiterates Hold on Sage Therapeutics
25 Apr 24
News, Reiteration, Analyst Ratings
Sage Therapeutics Expects Cash & Equivalents Plus Funding To Support Its Operations Into 2026; Expects ZULRESSO Revenues To Continue To Decrease Over Time
25 Apr 24
News, Guidance
Sage Therapeutics Q1 2024 GAAP EPS $(1.80) Misses $(1.65) Estimate, Sales $7.902M Beat $5.658M Estimate
25 Apr 24
Earnings, Earnings Beats, Earnings Misses, News
Hilton Worldwide Reports Upbeat Results, Joins Hasbro, Vertiv Holdings And Other Big Stocks Moving Higher On Wednesday
24 Apr 24
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
24 Apr 24
Movers
Scotiabank Maintains Sector Outperform on Sage Therapeutics, Lowers Price Target to $19
18 Apr 24
News, Price Target, Analyst Ratings
Oppenheimer Maintains Perform on Sage Therapeutics, Lowers Price Target to $17
18 Apr 24
News, Price Target, Analyst Ratings
In-Depth Examination Of 9 Analyst Recommendations For Sage Therapeutics
18 Apr 24
Analyst Ratings
TD Cowen Maintains Buy on Sage Therapeutics, Lowers Price Target to $16
18 Apr 24
News, Price Target, Analyst Ratings
Needham Reiterates Hold on Sage Therapeutics
18 Apr 24
News, Reiteration, Analyst Ratings
Crude Oil Dips 3%; U.S. Bancorp Profit Tops Views
17 Apr 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets, Trading Ideas
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
17 Apr 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
HC Wainwright & Co. Reiterates Neutral on Sage Therapeutics, Maintains $28 Price Target
17 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Wedbush Reiterates Neutral on Sage Therapeutics, Maintains $24 Price Target
17 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Nasdaq Down Over 1%; Sage Therapeutics Shares Plunge
17 Apr 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets, Trading Ideas
Neurodegenerative Disorder-Focused Sage Therapeutics Stock Falls On Disappointing Parkinson's Data
17 Apr 24
Biotech, News, Health Care, Top Stories, Movers, Trading Ideas, General
Press releases
Sage Therapeutics Announces First Quarter 2024 Financial Results and Highlights Pipeline and Business Progress
25 Apr 24
Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, Inc. - SAGE
24 Apr 24
News, Legal, Press Releases
Sage Therapeutics Announces Topline Results from Phase 2 PRECEDENT Study of Dalzanemdor (SAGE-718) in the Treatment of Mild Cognitive Impairment in Parkinson's Disease
17 Apr 24
Press Releases
Sage Therapeutics to Report First Quarter 2024 Financial Results on Thursday, April 25, 2024
11 Apr 24
Press Releases
Sage Therapeutics to Present at Upcoming March Investor Conferences
28 Feb 24
Press Releases
Sage Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Highlights Pipeline and Business Progress
14 Feb 24
Press Releases
Sage Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 14, 2024
31 Jan 24
Press Releases